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RESEARCH
Simian virus infections of humans are an increasing 
public health concern. Simian foamy virus (SFV) infections 
have been reported in persons occupationally exposed to 
nonhuman primates and in a few hunters in Cameroon. To 
better understand this retroviral zoonosis in natural settings, 
we studied persons who lived in southern Cameroon, near 
nonhuman primate habitats. First we studied a general popu-
lation of 1,164 adults; 4 were SFV positive according to se-
rologic and molecular assays. Then we studied 85 persons 
who reported having been bitten or scratched by nonhuman 
primates; 7/29 (24.1%) of those who had contact with apes 
(gorillas or chimpanzees) were SFV positive, compared with 
only 2/56 (3.6%) of those who had had contact with monkeys. 
These data demonstrate effi cient transmission of SFVs to hu-
mans in natural settings in central Africa, specifi cally follow-
ing ape bites, and viral persistence in the human host.
A large proportion of viral pathogens that have recently emerged in humans have originated in various ani-
mals. After initial interspecies transmission, these viruses 
have evolved and disseminated into the human population 
through various distinct mechanisms. However, under-
standing of the initial steps of the emergence of some vi-
ruses and associated diseases remains poor. Microbiologic 
studies of these high-risk populations are thus necessary to 
obtain new insights into the early events of this emergence 
process (1–4).
Nonhuman primates represent a potential source of mi-
crobes for humans (1,5–12), e.g., simian immunodefi ciency 
virus and simian T-cell lymphotropic virus (12–15). Simian 
foamy viruses (SFVs) are exogenous complex retroviruses, 
highly prevalent in several animal species in which they 
cause persistent infections (16–26). Phylogenetic analyses 
have demonstrated a species-specifi c distribution of such 
retroviruses. This species specifi city indicates a long-term 
coevolution of SFVs with their natural hosts (27), which 
could explain their possible lack of pathogenicity observed 
in vivo and the persistence of the infection (23,24,28–31). 
Among nonhuman primate populations, SFV seropreva-
lence can reach 75%–100% in adults, and SFVs appear to 
be present at high concentrations in the saliva of infected 
animals (16–18,22,29,31).
In humans, SFV infection has been reported in 1%–4% 
of persons occupationally exposed to nonhuman primates 
in zoos, primate centers, and laboratories, mainly in North 
America but also in Europe (7–10). More recently, natu-
rally acquired SFV infections were described in a few hunt-
ers living in Cameroon (11) and in 1 person who had had 
contact with Macaca fascicularis in Indonesia (32).
After other studies demonstrated high prevalence and 
genetic diversity of SFVs in monkeys and apes in Ga-
bon and Cameroon (16,17), we investigated the presence 
of SFV infection in humans living in these regions. Our 
goals were to 1) determine, by using specifi c serologic 
and molecular methods, the prevalence of SFV infection 
in the adult population of different ethnic groups (includ-
ing Pygmies) who lived in rural areas of Cameroon near 
natural nonhuman primate habitats and who were thus at 
risk for cross-species transmission; 2) trace the origin of 
the SFVs infecting these persons by isolation and molecu-
lar characterization of the virus; and 3) gain new insights 
into the epidemiologic determinants and risk factors linked 
to such naturally acquired retroviral infections, especially 
the type of nonhuman primates, the circumstances of the 
contact leading to the infection, and possible intrafamilial 
transmission of such viruses.
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Simian Foamy Virus Transmission from Apes to Humans
Materials and Methods
Populations
The fi rst study, a retrospective study, was based on 
a large series of samples collected during 1994–2000 for 
epidemiologic studies on human T-lymphotropic virus 
(HTLV)-1 and HTLV-2 as well as human herpesvirus 8 
(33,34). The samples originated from adults of 3 ethnic 
populations: Bakola Pygmies and 2 groups of Bantus, 
who lived in lowland tropical remote forest areas (Bipindi/
Lolodorf and Ntem) in southwestern Cameroon (Figure 1).
The second study, the hunter study, was conducted 
in 2004–2005 in remote villages near nonhuman primate 
habitats in the South Province of Cameroon (Figure 1). 
This study was focused on persons who reported direct and 
often severe contacts (bites, wounds, scratches, other inju-
ries) with animals, especially nonhuman primates, mainly 
while hunting.
Both studies received clearance from national and local 
authorities. All participants received detailed information 
about the study and gave consent. Blood samples were col-
lected in 5–10 mL EDTA tubes. Plasma was available from 
all participants in the retrospective study, whereas for some 
in the hunter study, only a few drops of blood were taken 
by fi ngerstick and conserved on fi lter paper (Whatman 
samples) as described (35). See online Technical Appen-
dix, available from www.cdc.gov/EID/content/13/9/1314-
Techapp.pdf, for more details.
Serologic Tests, Virus Isolation, and Molecular Studies
We screened by Western blot (WB) all plasma and 
Whatman samples for the presence of SFV antibodies as 
described (18,22,26). Plasma was tested at a 1:100 dilution. 
For each Whatman sample, a 1-cm punch was diluted in 1 
mL of phosphate-buffered saline and tested at a 1:8 dilution 
(online Technical Appendix). Virus isolation, electron mi-
croscopy, and immunofl uorescence (IFA) were performed 
as described (9,21,26,36; online Technical Appendix).
For the molecular studies, genomic DNA was ex-
tracted from the peripheral blood buffy coat by using the 
QIAamp DNA Blood Mini Kit (QIAGEN, Courtaboeuf, 
France). Two SFV proviral genomic regions (465 bp of 
the integrase gene and 109 bp of the long terminal repeat 
[LTR]) were amplifi ed in nested PCR (18,21,37). Integrase 
PCR products were purifi ed, cloned, and sequenced. The 
GenBank accession numbers of the 13 new integrase se-
quences are DQ838495–DQ838507. Phylogenetic analyses 
were performed as described (18,38,39; online Technical 
Appendix.)
Results
Retrospective Study 
The retrospective epidemiologic survey was performed 
among 1,164 adults (mean age 50.6 years) who lived in the 
Ocean region of Cameroon (Figure 1; Table 1). The studied 
populations included 478 Bakola Pygmies (mean age 47.6 
years) and 686 Bantus (mean age 52.6 years).
Of the 1,164 samples tested by WB assay based on 
chimpanzee foamy virus antigens, 21 (1.8%) were consid-
ered clearly positive (strong reactivity to both p70 and p74 
ape proteins, Gag doublet) (Figure 2, panel A), 86 (7.4%) 
were considered borderline/indeterminate (presence of ei-
ther a faint gag doublet or of at least a strong band of the 
right size and 1 or few other bands of often low intensity) 
(Figure 2, panel C), and the remaining 1,057 samples were 
considered negative (absence of any band) (Figure 2, panel 
C; Table 1). The 86 indeterminate samples were then tested 
by WB assay using antigens from a monkey foamy virus 
(originating from participant AG16, Figure 2, panel B); all 
were still indeterminate or negative.
DNA was available from 11 of the 21 persons whose 
WB assay results were positive and from 52 of 86 whose 
results were borderline/indeterminate. All 63 DNA sam-
ples were amplifi able by PCR for β-globin gene. When in-
tegrase primers were used, PCR was positive for 4 of 63 
samples (Table 2). When LTR primers were used, PCR was 
positive in 3 of these 4 samples (Table 2).
Field interviews indicated that 3 persons (2 Bakola Pyg-
mies [801001 and 210301] and 1 Bantu [60601]) were fre-
quent hunters and had been severely bitten by gorillas 25–35 
years ago (Table 2); all 3 had scars on their legs and fi ngers 
(Figure 3). The fourth infected person (A051302) was a Ban-
tu woman who did not recall any bites or injuries from mon-
keys or apes. However, she had had frequent contact with 
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Figure 1. Geographic distribution in Cameroon of the studied 
populations and the 13 persons infected by simian foamy virus 
(SFV), according to serologic and molecular results. Red, SFV-
positive persons from the hunter study; green, SFV-positive persons 
from the retrospective study; blue circle, Pygmy area; violet circles, 
Bantu areas.
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wild game meat from nonhuman primates while butchering 
and preparing meals, as is common in this area (3,4).
Sequence analyses of the 4 integrase gene fragments 
indicated that the 3 persons bitten by gorillas were infected 
with a gorilla foamy virus. These 3 sequences were simi-
lar to the sequence CAM1083 (96.7%–98.5% identity) re-
ported in a Cameroonian hunter infected by a gorilla foamy 
virus (11) and to known sequences of foamy virus from go-
rillas living in Cameroon and closely related to each other 
(97%–99% identity). The Bantu woman had been infected 
by a chimpanzee belonging to Pan troglodytes troglodytes, 
1 of 2 chimpanzee subspecies endemic to Cameroon (on-
line Appendix Figure, available from www.cdc.gov/EID/
content/13/9/1314-appG.htm). 
Hunter Study
Our next step was to not only characterize more cases 
of such interspecies transmission, looking especially for 
viral acquisition from other nonhuman primates, but also 
to assess the frequency of such phenomena and to defi ne 
the parameters that characterize a risk population. Thus, we 
focused our work on persons who had regular contact with 
nonhuman primates, hunters in lowland rain forest regions.
During 2004–2005, fi eld missions were initiated in 
remote villages of Bantus and Baka Pygmies in different 
areas of south Cameroon. In each village we specifi cally 
asked for persons who had had direct contact and severe 
bites, scratches, wounds, other injuries from animals, main-
ly nonhuman primates.
This study included 102 persons, 84 men and 18 wom-
en, most of them adults (mean age 40 years, range 2–80 
years). Of these 102, 29 (28.4%) had had contact with 
apes (gorillas, chimpanzees), and 56 (54.9%) with mon-
keys (Cercopithecus nictitans), mandrills, and a few other 
small monkeys not precisely identifi ed). Thus, 85 of 102 
had been in contact with nonhuman primates. Contact with 
rats, elephants, warthogs, duikers, squirrels, porcupines, 
and leopards was reported by 17 (16.6%).
From the 102 persons, we obtained 61 plasma samples 
and 41 dried blood spots. All samples were tested by WB, 
and 10 (9.7%) were clearly SFV seropositive (Figure 2). 
Of 15 specimens that were indeterminate/borderline, WB 
based on monkey FV antigens (originating from participant 
AG16) showed them all to be negative or indeterminate.
PCR performed on the available DNA (from the 10 
WB-seropositive, 8 sero-indeterminate, and 33 seronega-
tive persons) gave positive results for the integrase gene 
in 9 of the 10 WB-positive samples (Table 2) and negative 
results for the others. The LTR PCR was positive for 7 of 9 
integrase-positive samples and none of the 42 others.
All 9 SFV-positive persons belonged to the group 
of 85 persons who had had known contact and bites or 
scratches from apes or monkeys. Thus, the subsequent epi-
demiologic analysis was restricted to these 85 (71 men, 14 
women; mean age 39 years). According to univariate analy-
sis, foamy virus–positive serologic results were associated 
with the type of nonhuman primate encountered (monkeys 
3.6% vs. apes 24.1%, p = 0.003) and the type of encounter 
(pets 0% vs. hunting 16.1%, p = 0.022) (Table 3). No other 
studied risk factor (except age at time of contact) was sig-
nifi cantly associated with positive results.
Among the 56 persons who had received severe bites 
or scratches from nonhuman primates while hunting, 7 
(36%) of the 19 that had encountered an ape were infected 
with SFV, in contrast to only 2 (5.4%) of 37 who had had 
contact with a small monkey (p<0.05) (data not shown). To 
determine possible intrafamilial transmission of SFVs, we 
tested 4 wives and 1 husband of 5 of the index case-par-
ticipants as well as 5 of their children (Table 2). All were 
seronegative according to WB.
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Table 1. Serologic results for simian foamy virus retrospective study, rural Cameroon, 1994–2000 
Study population Test results 
Area Ethnicity Age range, y Total no. Men Women Negative
Borderline,
no. (%) 
Positive,
no. (%) 
Bakola
Pygmies 
30–82 478 214 264 448 16 (3.34) 14 (2.92) Bipindi Lolodorf 
Bantus 40–83 370 180 190 326 40 (10.81) 4 (1.08) 
Ntem Bantus 20–78 316 144 172 283 30 (9.49) 3 (0.9) 
Total 20–83 1,164 538 626 1,057 86 (7.38) 21 (1.8) 
Figure 2. A) Western blot (WB) results based on chimpanzee (cpz) 
simian foamy virus (SFV) antigens. B) WB results based on monkey 
simian foamy virus antigens originating from participant AG16. C) 
Example of sero-indeterminate samples (lanes 1–7) and negative 
samples (lanes 8–13), detected by cpzSFV WB. Last lane (POS 
cpz), serum from an SFV-positive chimpanzee.
Simian Foamy Virus Transmission from Apes to Humans
Of the 9 SFV-positive persons, 7 had been severely 
bitten by a gorilla (4 persons) or chimpanzee (1 person) 
1–53 years ago while hunting (Table 2); some displayed 
large scars on the legs, arms, feet, or fi ngers (Figure 3). 
Hunters CH66 and CH29 had been severely bitten by 2 dif-
ferent animals in 2 separate hunting incidents. The 2 other 
SFV-positive persons were adult men who had been bitten 
by a small monkey, including a mandrill and a C. nictitans 
(Table 2).
Phylogenetic analyses of the 9 integrase products in-
dicated that all belonged to the large clade of the African 
SFVs with 5 strains from gorilla, 2 from chimpanzee, 1 from 
mandrill, and 1 closely related to Cercopithecus strains (on-
line Appendix Figure). The 2 hunters who had been bitten by 
2 different animals were infected with chimpanzee (CH66) 
and gorilla (CH29) foamy viruses, respectively.
Thus, for each of the 9 case-participants, the match 
was nearly perfect between the history of contact with a 
given nonhuman primate species (mainly through severe 
bites that had occurred decades ago) and the simian virus 
sequence that was found in the infected person (Table 2).
In Vivo Virus Persistence
Because each of the 6 persons from whom we obtained 
2 samples (plasma, dried blood spots, or both) at different 
times was SFV positive by WB, persistent infection was 
evident for each person. The duration of this persistent in-
fection was 1–8 years.
Isolation of 2 New Foamy Virus Strains
SFV was assayed for 2 persons (AG15 and AG16) from 
whom blood was available for culture. Giant-cell formation 
and syncytia were fi rst observed for AG15’s sample after 
26 days of coculturing, whereas cytopathic effect (CPE) 
was detected only after 33 days for AG16’s sample. The 
destruction of the monolayer of BHK-21 was quite rapid 
(2–4 days) after the fi rst appearance of the CPE. Syncytia 
and giant cells showed a strong and clear specifi c immuno-
fl uorescence (Figure 4).
Electron microscopic analyses of cultured cells with a 
strong CPE demonstrated the presence of multinucleated 
giant cells. Typical foamy virus particles (diameter 100–
110 nm) were frequently observed with several envelope 
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Table 2. Demographic and epidemiologic features, serologic and PCR results, 13 SFV-infected inhabitants of rural Cameroon*  
Participant code, 
sex, ethnicity 
Year(s) of 
sample
collection
Age at sample 
collection, at 
animal contact, y 
Type of 
animal
Wound
location
Serologic
results 
(specimen)
LTR/
Intergase
PCR
Integrase
sequence
Viral load, 
copies/500
mg DNA 
60601, M,
Bantu†‡
1999 67, 30 Gorilla, 
monkey 
Finger + (plasma) +/+ Gorilla 10–100
801001, M,
Pygmy†‡§ 
1996,
1998
60, 35 Gorilla Leg + (plasma) +/+ Gorilla 100–1,000
210301, M,
Pygmy†‡ 
1996,
2004
68, 35 Gorilla Leg + (plasma) -/+ Gorilla 1–10
51302, F,
Bantu†‡§
1998 40, NK None? NK + (plasma) +/+ Chimp. 100–1,000
CH29, M,
Pygmy¶ 
2004,
2005
50, 49 Chimp.,
gorilla 
Finger,
foot
+ (DBS,
plasma)
+/+ Gorilla 1–10
CH61, M,
Bantu*§¶
2004,
2005
65, 52 Gorilla Hand,
arm
+ (plasma) +/+ Gorilla 10–100
CH65, M,
Pygmy¶ 
2004 58, 26 Gorilla Head,
arm
+ (plasma) +/+ Gorilla 1–10
CH66, M,
Pygmy¶ 
2004 60, 56 Cerco.
nictitans,
Chimp.
Hand,
foot
+ (plasma) +/+ Chimp. ND
CH86, M,
Bantu†¶
2004 62, 47 Gorilla Hand + (plasma) +/+ Gorilla 1–10
CH99, M,
Bantu¶
2004 26, 25 Monkey, 
species?
Hand + (plasma) –/+ Mandrill 1–10
CH101, M,
Bantu¶
2004 76, 65 Gorilla Hand + (plasma) +/+ Gorilla 1–10
AG15, M,
Bantu¶
2004,
2005
71, 28 Chimp. Hand,
foot
+ (DBS, 
plasma)
+/+ Chimp. 100–1,000
AG16, M,
Bantu¶
2004,
2005
43, 23 Monkey 
Cerco.
Foot + (DBS,
plasma)
–/+ Cerco. 1–10
*SFV, simian foamy virus; LTR, long terminal repeat; +, positive; –, negative; DBS, dried blood spot; NK, not known; Chimp., chimpanzee; ND, not 
determined; Cerco., Cercopithecus. The age at contact with nonhuman primate and the type of animal contact concern the results of the field interviews 
performed for each person found to be infected by SFV.  
†Wife or husband also tested. 
‡Retrospective study participant. 
§1 (A051302) or 2 (CH61 and 801001) children also tested. 
¶Hunter study participant. 
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spikes and a spherical central core (Figure 4). Budding of 
such virus particles was observed, mainly from the mem-
brane surface of the endoplasmic reticulum.
PCR was performed on DNA extracted from the viral 
isolates after 2 months of culture. Comparative sequence 
analyses of the integrase product showed 100% nucleo-
tide identity for AG16 (Cercopithecus strain) and 99.8% 
for AG15 (chimpanzee strain) between the SFV sequences 
from the peripheral blood mononuclear cell uncultured 
DNA and the cultured viral isolate.
Foamy Virus Load in Buffy Coat
To determine the peripheral blood viral load in persons 
infected by SFVs and to check whether the discrepancies in 
the results between the 2 PCR assays (integrase and LTR) 
could be related to a low viral load (reaching the limits of 
our PCR sensitivity), we used a semiquantitative PCR as-
say (18). Of the 13 infected persons, 7 (Table 2) had a very 
low viral load, 1–10 copies in 500 ng of total DNA. For 
only 4 (all of them positive for both nested PCRs), the viral 
load was higher, 100–1,000 copies in 500 ng of total DNA 
(Figure 5; Table 2).
Discussion
Animal reservoirs are one of the most important sourc-
es of emerging infectious diseases that threaten humans. 
Recent zoonotic transmission of retroviruses has led to the 
emergence of HIV-1 and HIV-2 in humans (13). Nonhu-
man primates are natural hosts for other retroviruses. Al-
though SFVs have been recently shown to infect persons 
occupationally exposed to nonhuman primates in zoos and 
primate centers, little is known about modes of cross-spe-
cies transmission of these viruses in their natural habitat.
In the current study of adults living in central African 
regions with high nonhuman primate diversity, ≈2% of 
1,164 persons showed clear seroreactivity to SFVs and at 
least 4 were persistently infected with SFV, with detectable 
viral sequences in their peripheral leucocyte DNA. These 
results confi rm and extend to other areas of Cameroon the 
original fi ndings published by Wolfe et al., who found that 
10 (1%) of 1,099 of a comparable population had antibod-
ies to SFV with a positive PCR for only 3 of them (11). 
These data, combined with the fi ndings of our hunter study, 
which identifi ed 9 more SFV-infected persons, demonstrate 
infection by a large diversity of SFVs in persons from geo-
graphically isolated areas. Such retroviral zoonosis is thus 
widespread and occurs in diverse villages where hunters 
are frequently in contact with nonhuman primates (3,4). In 
another context, a model has predicted that in Bali, Indone-
sia, for every 1,000 visitors to a monkey temple, approxi-
mately 6 will be infected with SFV (40).
Our study demonstrates effi cient transmission of SFVs 
to persons in natural settings in central Africa, specifi cally 
after the persons had been bitten while hunting, and a viral 
persistence in the human host. Indeed, >35% of the hunters 
bitten severely (often with soft tissue crushing, tearing, and 
bleeding) by a gorilla or a chimpanzee were SFV infected. 
This strongly suggests that in a natural situation, contact of 
human blood with the saliva of an adult ape or monkey is 
the key factor for SFV transmission to humans. This situa-
tion is similar to that of persons occupationally exposed to 
nonhuman primates in zoos and primate centers, as nearly 
all of them reported having been bitten by monkeys or apes 
(5,9,10). Some studies have shown that SFVs are present at 
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Figure 3. Wounds resulting from bites or scratches from a 
nonhuman primate. A) Participant no. 801001. B) Participant no. 
AG16. C) Participant no. 210301. 
Table 3. Univariate analysis results for risk factors for simian 
foamy virus, 85 persons, rural Cameroon* 
Risk factor 
Total no. 
tested
Positive,
no. (%) p value 
Age at contact, y 
>45 65 4 (6.2) 
 <45  20 5 (25) 0.017
Sex 
 Male 71 9 (12.7) 
 Female 14 0 0.159
Ethnicity 
 Bantu 72 6 (8.3) 
 Pygmy 13 3 (23.1) 0.112
Type of animal interaction 
 Pet† 29 0
 Hunted  56 9 (16.1) 0.022
Type of nonhuman primate 
 Monkey 56 2 (3.6) 
 Ape 29 7 (24.1) 0.003
Wound type 
 Scratches 9 0
 Bites 76 9 (11.8) 0.275
Wound location
 Upper body 31 2 (6.5 ) 
 Lower body 54 7 (13) 0.348
Scars
 Absent 12 0
 Present 73 9 (12.3) 0.198
*Only the 85 persons with nown severe bites or scratches from a 
nonhuman primate. Univariate analyses were performed by using STATA 
(StataCorp LP, College Station, TX, USA) software with the χ2 and Fisher 
exact tests with critical p value = 0.05.  
†Most pets were Cercopithecus nictitans and mandrills; some were small 
chimpanzees. 
Simian Foamy Virus Transmission from Apes to Humans
high concentration in the saliva (with viral replication) of 
infected animals (29,31). We recently provided evidence 
that Macaca tonkeana mostly acquire SFVs through severe 
bites, mainly young adults when they compete for sex part-
ners (18). In our study, contact with pets was not found to 
be associated with SFV infection. This might be because 
pet bites mainly cause superfi cial tissue damage and rarely 
cause serious wounds and because some of the animals are 
probably not SFV infected due to their young age when 
captured. 
In our study, SFV integrase or LTR sequences were not 
detected in several of the persons who were confi rmed sero-
positive by WB. Although the presence of divergent SFVs 
could explain such discrepancy, low viral load in the blood 
samples is more likely, because our PCR primers have been 
shown to amplify a large variety of African SFVs but also 
several rather divergent Asian SFVs (16–18,22). This lack 
of detection of FV sequences by PCR may also indicate 
nonspecifi c reactivity with SFV Gag antigens. Lack of SFV 
sequences has also been recently reported in the peripheral 
blood mononuclear cell DNA of 7 of 10 African hunters 
who were SFV seropositive according to WB (11).
We provide the fi rst data, to our knowledge, on the 
quantifi cation of viral load of SFVs in humans. Our results, 
based on 13 infected persons, indicate a low viral load in 
most persons but a large range (1–1,000 copies in 500 ng of 
total peripheral blood leukocytes DNA). These viral loads 
are comparable to those in wild-born chimpanzees (16) and 
captive M. tonkeana (18).
Our work did not demonstrate the presence of SFV in 
the spouses of 5 index case-participants and in 5 of their 
children. Combined with the scarce published fi ndings 
on this topic, these results suggest that SFV transmission 
among humans does not occur easily by sexual contact or 
saliva exposure (8–10).
Another concern is the illness and death that might be 
associated with these retroviral persistent infections after 
interspecies transmission. The apparent lack of pathogenic-
ity of SFV infection in humans, which is still based on a 
limited number of cases, contrasts strongly with the mas-
sive in vitro lytic properties of these viruses in monkey and 
human cells (8–10,18,30). The selection bias inherent in 
the enrollment of healthy persons in our study, as well as in 
those enrolled by Wolfe et al. (11) and Switzer et al. (10), 
greatly limits the ability to identify any potential acute or 
severe associated diseases. A case-control study based on 
a larger number of SFV-infected persons would help shed 
light on possible chronic diseases or biological abnormali-
ties associated with human SFV infection. SFV infection in 
immunocompromised persons, especially those with HIV 
infection, could also heighten public health concerns be-
cause such coinfection is probable in central African areas 
where HIV-1 is highly endemic.
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